Outpost Bio is decoding the hidden interactions that drive human biology. The company combines high-throughput assays of human-derived microbial communities with machine learning to build frontier models that reveal causal pathways - not just correlations. Headquartered in Boston and London, the company enables any partner developing molecules that go into or onto humans to predict microbe-mediated metabolism, toxicity, and response - making human microbiology computable for the first time.
- Life Sciences
- London, United Kingdom
- £2.6m
- outpost.bio
- Update Information
More venture news
- 18 Sept 2026

Big Picture BioBig Picture Bio raises a £1.5m pre-seed round led by Kadmos Capital and Exceptional Ventures to design cancer combination therapies
Pre-seedLife Sciences - 16 Sept 2026

Eterna RegenerativesEterna Regeneratives closes a seed round led by Hoxton Ventures and The Venture Collective to develop keratin-based enamel repair
SeedLife Sciences - 15 Sept 2026

Magnitude BiosciencesMagnitude Biosciences raises £1.3m led by Northstar Ventures to run drug discovery screens in living nematode worms
EquityLife Sciences
